Are Medical Stocks Lagging Aquestive Therapeutics (AQST) This Year?

Company Performance - Aquestive Therapeutics (AQST) has gained approximately 93.3% year-to-date, significantly outperforming the Medical sector, which has returned an average of 0.2% during the same period [4] - The Zacks Consensus Estimate for AQST's full-year earnings has increased by 11.8% over the past 90 days, indicating improved analyst sentiment and a more positive earnings outlook [3] Industry Comparison - Aquestive Therapeutics is part of the Medical - Drugs industry, which consists of 146 individual stocks and currently ranks 78 in the Zacks Industry Rank. This industry has seen an average gain of 7.3% year-to-date, showcasing AQST's superior performance within this category [5] - In comparison, Arcturus Therapeutics (ARCT), another Medical stock, has increased by 25.2% year-to-date and belongs to the Medical - Biomedical and Genetics industry, which has a current rank of 88 and has moved up by 8.2% year-to-date [4][6]